Luis Andrés López-Fernández

14PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersInnate immunityGene and molecular therapyAutoimmunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 28, 2026
Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive DPYD Pharmacogenetic Testing.

María Rodríguez-García, Sara Salvador-Martín, Mariam Stephanie Rojas Piedra

|Apr 17, 2025
Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy.

Paula Zapata-Cobo, Sara Salvador-Martín, Sergio Gil-Manso

|Oct 26, 2024
An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health System.

Irene Taladriz-Sender, Gina Hernández-Osio, Paula Zapata-Cobo

|Oct 14, 2023
Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis.

Alberto Lozano-Ros, María L Martínez-Ginés, José M García-Domínguez

|Jan 21, 2023
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.

Sara Salvador-Martín, Paula Zapata-Cobo, Marta Velasco

|Oct 27, 2022
Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain.

Adrián Bravo-Gómez, Sara Salvador-Martín, Paula Zapata-Cobo

Pageof 3